SlideShare a Scribd company logo
DR. VIVEK B WANI MS FRCSED
Consultant Vitreoretina surgeon
KLES Dr Prabhakar Kore Hospital & RC
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 1
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 2
Who is this?
OBJECTIVES OF THIS TALK
Give an overview of ROP
Highlight the role of neonatologists
in management of ROP
 Which babies are for ROP screening
 How to arrange ROP screening
 How to manage discharged babies
 Medico-legal aspects of ROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 3
Subheadings of the talk
 Overview of ROP
 Introduction
 Definition of ROP
 History and epidemiology
 Pathogenesis
 ROP clinical features and classification
 Risk factors for ROP
 Treatment guidelines and results
 Role -of neonatologists
 Screening protocol
 Whom, when, how, follow ups and medico-legal aspects
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 4
Introduction
WHY SHOULD PEDIATRICIANS KNOW ABOUT
ROP?
 There are good reasons
 There are bad reasons
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 5
Good reasons are
 By knowing about ROP- you refer at risk babies to
ophthalmologists in time and prevent blindness
 Blindness in babies is for life
 That is a noble service!
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 6
Prompt reference, proper screening and laser treatment
done in BE 20 years ago -Now a graduate in US
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 7
Bad reasons to know about ROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 8
BE AWARE OF ALL PROTOCOLS AND
DO YOUR PART IN CARE OF ROP TO
AVOID SUCH MEDICOLEGAL cases
Definition of ROP?
ROP is a vaso-
proliferative
disorder of the
retina in
premature babies
with immature
retina - avascular
area
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 9
History of ROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 10
Terry 1942 -- two cases of white membranes behind the lenses in
premature babies and termed it as Retrolental Fibroplasia
(RLF)1
Campbell and Patz showed that premature babies receiving
higher oxygen supplementation developed RLF2,3
,
1.Terry TL. Am J Ophthalmol 1942;25:203-204
2. Campbell K. Med J Aust 1951;2:48–50
3. Patz et al Am J Ophthalmol 1952;35:1248–52
Knee jerk reaction-curtail oxygen
 Reducing oxygen led to reduction in RLF from 50% to
4%4
 BUT- a very high rate of mortality and morbidity due
to cerebral palsy 5
 It was estimated that by reducing oxygen-for every
baby they saved the sight- there were 16 babies who
either died or had cerebral palsy6
 So oxygen was restarted to be used
4. Hatfield EM. Sight Sav Rev 1972;42:69–89
5.. Avery ME, Oppenheimer EH. J Pediatr 1960;57:553–9.
6. Cross KW. Cost of preventing retrolental fibroplasia? Lancet. 1973;2:954–6
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 11
Three Epidemics of ROP
 First epidemic of RLF or ROP was in 1940s-
50s –soon after oxygen was introduced for
premature babies- none knew about ROP
 Second epidemic started in 70s-80s
Due to liberal use of oxygen to prevent
cerebral palsy or death7
Due to increased survival of smaller babies8
7.Gibson DL et al Pediatrics 1989;83:486–92.
8.Valentine PH et al. Pediatrics 1989;84:442–5
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 12
The third epidemic -1990s onwards
 Advances and expansion of neonatal services in
middle income countries like India, China, Mexico,
Brazil etc are occurring
 More premature babies are surviving
 So ROP is increasing in these countries -3RD WAVE
 It is still going on
 It is our duty to expand ROP services to cover every
neonate
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 13
How big is ROP problem?
 13 million premature babies born every year in the world
 And severe ROP in more than 50 000 babies every year9
 One in 820 babies born premature may become blind due to
ROP10
 An estimated 32000 children went blind world wide in 2010
and 10% of them were in India11
 ROP is an important cause of blindness during childhood12
9. Blencowe H et al. Pediatr Res. 2013;74(Suppl 1):35-49
10. Lad et al Br J Ophthalmol 2008;92:320-325
11. Blencowe H et al Indiann Paediattrics 2016;53:supl 2
12. Steinkuller PG et al J AAPOS 1999;3:26 –32.
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 14
How does fetal retinal vasculature develop?
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 15
• At 12 weeks of gestation
mesenchymal cells grow out
from the disc
• They form capillaries, venules
and arterioles and then major
vessels
• The avascular retina produce
a cytokine vascular
endothelial growth factor –
VEGF-which promotes
vascularization of retina
• Vessels reach nasal periphery-
ora serrata- at 32 weeks of
gestation and temporal
periphery at term
• So by term, the retina is
fully vascularized LEFT EYE
So if a baby is born premature
 Some avascular retina will be
present -extent depends upon
prematurity
 In such babies
retinal vessels may grow
towards the ora to complete
vascularization of retina in a
normal fashion or
ROP may develop in some
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 16
Pathogenesis
Pathogenesis of ROP occurs in two phases13-15
 Hyperoxic phase
 Hypoxic phase
13. Chen J, Smith LE. Angiogenesis. 2007;10:133-140.
14. Hartnett ME. Ophthalmology. 2015;122:200-210.
15. Mintz-Hitner HA et al N Engl J Med. 2011;364:603-615
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 17
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 18
In utero baby lives in hypoxic environment -PaO2 of < 30 mm of Hg.
Hypoxia promotes normal VEGF expression which facilitates
vascularization of retina
If a baby is born premature it is exposed to higher PaO2 of 100 mm
of Hg in room air. Baby may also receive O2 treatment
High PaO2 –no hypoxia - VEGF expression suppressed –needed for
normal growth of blood vessels -so vessel growth stops –vaso-cessation
high PaO2 in blood -O2 radicals –death of endothelial cells of
growing retinal vessels –cause obliteration –vaso-obliteration
Vessels and capillaries stop growing to periphery
The peripheral retina remains avascular - becomes hypoxic -
hypoxia triggers next phase of pathogenesis-HYPOXIC PHASE
HYPEROXIC PHASE 22 to 30 weeks of PMA
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 19
Phase 2 –HYPOXIC PHASE-31 to 44 weeks of PCA
Hypoxia causes up-regulation of VEGF and other
growth factors in retinal cells in avascular retina
High VEGF and other growth factors lead to
active ROP and abnormal vaso-proliferation
ROP develops at the junction between
vascularized and avascular retina
These cells now produce VEGF, EPO and IGF1
VEGF levels increase -130 times normal values
.
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 20
16. Invest. Ophthalmol. Vis. Sci.. 2008;49(12):5177-5182
Classification of ROP
 International classification of ROP(ICROP) 17 issued
guidelines to uniformly describe ROP in 1984
 Further modifications for this have occurred
subsequently but basic aspects remain same
17. ICROP GROUP Arch Ophthalmol 1984;102:1130-1134
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 21
ROP – ICROP17
1) Location
2) Staging
3) Extent
4) Plus disease
17. ICROP GROUP Arch Ophthalmol 1984;102:1130-1134
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 22
1) Location –Zone-
tells us where the disease is located
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 23
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 24
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 25
2) Stages of ROP
Stage 1-demarcation line
A simple flat line is seen at the edge of advancing vessels
separating avascular from vascular retina
Stage 2-Ridge
The demarcation line becomes thick and has volume
and height –then it is called as ridge-stage 2
It is pinkish or whitish
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 26
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 27
Stage 3
 When new blood vessels called as extra-retinal
proliferations (ERP) develop in addition to the ridge
New vessels may grow
into vitreous or
back on the surface of vascularized retina from the
ridge area giving it ragged appearance
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 28
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 29
Stage 3
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 30
Do all babies who develop stage 1
or 2 progress to stage 3 ROP?
No
 Many babies who develop stage 1 or 2 show
spontaneous resolution of disease
 Retina may become fully vascularized
 Some cases of Stage 3 also show regression
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 31
We should not see this stage
Stage 4-subtotal retinal detachment
When extensive ERP
contract they pull
retina TRD
Stage 4a
 Macula not involved
Stage 4b
 Macula is involved
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 32
Stage 5- we should never see it
 Total retinal
detachment
 Results of surgery
very poor
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 33
3) ICROP- Extent of the disease
 We note how many clock
hours of disease is
present
 Report as so many clock
hours of the disease
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 34
4) ICROP- 4th component is plus disease MOST
IMPORTANT SIGN
 Dilatation and tortuosity of the posterior vessels in
zone 1
 Vitreous haze
 Pupil rigidity-does not dilate well
 Iris vessel engorgement, iris new vessels
PLUS disease is a very important sign and its presence
is usually an indication for treatment
Further classified as pre-plus or plus
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 35
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 36
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 37
Tunica vasculosa lentis
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 38
ZONE I stage 3 plus disease
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 39
When do we treat ROP
 The purpose of screening is to catch ROP at treatable
stage and prevent stages 4 and 5
 The window of opportunity is small in ROP
 One missed appointment -baby may progress from stage 2
to stage 4 or stage 5
 So screening a timely protocol is very important
 RCTs have established guidelines for treatment
 We follow ETROP study guidelines for indications of
treatment 18
18. Early Treatment of Retinopathy of Prematurity Group. Arch Ophthalmol. 2003;121:1684-1694
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 40
Type1 ROP (treatment is required)18
 Zone I-stage 1 OR 2 ROP with plus disease
 Zone I-stage 3 ROPeven without plus disease
 Zone II-stage 2 or 3 withplus disease
Treatment is
 Retinal ablation of all the avascular retina by laser is
established form of treatment
 However presently zone I ROP is treated by
intravitreal injection of anti VEGF
18.Early Treatment of Retinopathy of Prematurity Group. Arch Ophthalmol. 2003;121:1684-1694
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 41
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 42
ROP that does not meet the criteria of type 1 ROP is
termed as Type 2 ROP
 Zone I, stage 1 or 2 ROP without plus disease
 Zone II, stage 2 or stage3 ROP without plus disease
 No treatment is required at that point of time
 But continued follow up is needed
 If progresses to type I treat the baby
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 43
Aggressive ROP-AROP or APROP
 It is fulminant variant of ROP
 Seen usually in very small babies
 ROP is in the zone 1 or posterior zone 2
 Rapidly progresses to higher stages without starting
with stage 1 or 2
 Has disproportionate plus disease
 Neovascularization of retina may be intraretinal
 Treatment results are less satisfactory
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 44
ZONE I DISEASE - APROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 45
How do we treat
A) Laser –laser burns applied to all the avascular
retina which is hypoxic -is producing VEGF. Once is
‘destroyed’ VEGF comes down and
The ROP regresses
B) Anti VEGF injections–in eyes with zone I disease
or aggressive ROP(A-ROP)
 Anti VEGF – it neutralizes high levels of VEGF in the
eye and stops neovascularization
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 46
Laser treatment
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 47
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 48
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 49
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 50
What are the risk factors for ROP
 Lower Gestational age at birth-prematurity
 Lower Birth weight-prematurity
 Oxygen administration
 Need for ventilation
 HMD
 CLD
 Sepsis
 Intra-ventricular hemorrhage
 Need for blood transfusion
 Poor postnatal weight gain
 NEEC
 PDA
 Many other factors
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 51
Oxygen spO2
 Keeping SpO2 83% and 93% from birth and during
transport virtually eliminated severe ROP
 Need for laser treatment was 4.5% for high SpO2
(90%–98%) versus 0% for low SpO2 (85%–93%)19
19.Chow LC, et al . Pediatrics. 2003;111:339–45.
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 52
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 53
EVENT HIGHER
OXYGEN
91-95%
LOWER
OXYGEN
85-89%
RR LEVEL
P VALUE
MEANI
NG
PRIMARY
OUTCOME
51.6% 53.5% P=0.21 NS
DEATH 17.1% 19.9% P=0.01 S
ROP treatment
need
14.9% 10.9% P < .001 S
NEEC 6.9% 9.2% P = .003 S
NEOPROM STUDY20
20. Askie LM et al JAMA. 2018 Jun 5;319(21):2190-2201.
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 54
21
21. Wani et al Indian J Ophhthlamol 2010;58: 204-208
22. Middle East Afr J Ophthalmol.2013;20(1):66-71.
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 55
Incidence of ROP and type I ROP-KLE experience 2019 one year
data
1/6/2023 56
Study and place of
study
Number of
infants
Inclusion criteria
GA* and BW†
Mean BW± SD in grams
GA± SD in weeks
Any ROP%
Type 1 ROP%
Quinn et al 6
USA
7483 GA≤30
BW<1500g
28 ± 3
1099± 259
43.1
6.9
Braimah et al7
Ghana
401 GA<37
BW<2000
32.2± 2.4
1600± 400
13.7
1.8
Bas et al 10
Turkey
6115 GA<32 W
BW <1500G
1457±479
28.9±6.3
27
6.7
Ahuja et al11
India
325 GA≤36 W
BW ≤1900G
1420±300
30.68±2.84
32.6
13.2
Vinekar et al 14
India
4167 GA<34
BW<2000G
1592.7
31.7
24.33
4.4
Castellon et al21
Mexico
132 GA≤34
BW <1700g
1594±96
32±3
56.1
28.8
ETROP study23
USA
6998 BW <1251g 907
27.4
68
36.9
Present study 263 GA<34
BW<2000G
1598.8 ±440.1
33± 2.8
24.3
5.7
Results of treatment of ROP till
2021 in KLE
 55 babies(KLE BORN AND OUTSIDE BORN)
 GA 30.1( 27-33)weeks
 BWT 1299.7( 718-2500)g
 PCA at treatment 35.9 weeks
 AROP in 6 babies
 20 treated by anti vegf injections
 None developed RD
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 57
Role of Pediatricians in ROP
Which premature babies to screen?23
Following guidelines are from Govt. of India
 Birth weight(BW) less than or = 2000g
 Gestational age(GA) less than or =34 weeks
 GA 34-36 weeks n BW >2000G but has following
risk factors
a) Cardiopulmonary support b) Prolonged oxygen administration c)Respiratory
distress syndrome d) Chronic lung disease e)Fetal hemorrhage f)Blood transfusion
g)Neonatal infection h)Exchange transfusion i)Intraventricular hemorrhage j)Apneas
k)Poor postnatal weight gain
 Infants with unstable clinical course who are at
high risk (as determined by neonatologist)
23 https://nhm.gov.in/images/pdf/programmes/RBSK/Resource_Documents/Revised_ROP_Guidelines-Web_Optimized.pdf
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 58
Who chooses the babies for
screening?
 The neonatologist will choose the babies
 All the names of eligible babies are entered in a
register by an assigned staff and date for first screening
to be entered in the register
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 59
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 60
Rashtriya Bala Swasthya Karykrama
June 201723
When to perform the first ROP
screening?23
 Early screening for babies born with GA < 28 weeks
OR babies with BW<1200g
-first ROP screening at 2-3 weeks after birth (To detect
AROP)
 All other babies undergo the first ROP screening at
four weeks after birth
23. https://nhm.gov.in/images/pdf/programmes/RBSK/Resource_Documents/Revised_ROP_Guidelines-
Web_Optimized.pdf
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 61
Sample register entry
Name
of
baby
IP
nu
mbe
r
DOB SE
X
GA
wk
s
BW
g
I ROP
screening
date
Mobile
of
parent
s
b/o
ABC I
twin
32**
****
01/01/2018 M 29 1150 14 or 21 of
January 2018
988****
***
b/o
ABC II
twin
32**
****
01/01/2018 M 29 1240 28TH JAN 2018 same
b/o
MNO
33**
****
25/01/2018 F 30 1400 25/2/2018 944****
***
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 62
Baby unfit for eye examination
In case the baby is too sick to tolerate dilatation & ROP
screening is postponed
Neonatologist should
 Clearly write in the case sheet the reason for
cancellation of screening examination
 ROP screening at the earliest possible to be arranged
 Inform the parents
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 63
Who performs the screening?
 It is an ophthalmologist who is experienced in ROP
examination and management
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 64
Arrangement regarding visit of the Ophthalmologist to the
nursery
 Neonatology and Ophthalmologist should arrange
day/days to conduct ROP screening examination/s
 Usually a fixed day and timings are preferred to avoid
confusion except under special circumstances
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 65
Arrangement regarding visit of the Ophthalmologist to the
nursery
 The staff of NICU should inform the timing of eye
examination to all the sections of the Neonatology
dept-NICU, WARDS, OPDs
 Babies for first time ROP screening and follow up
examinations are to be included (see later)
 Keep the pupils dilated of all the selected babies
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 66
The method for dilatation of the pupils
1) 0.5% Tropicamide every 15 minutes for three times-0,15,30
minutes
OR
2) Cyclopentolate 0.5% eye drops (Cyclogyl) to be used every 15
minutes for three times 0, 15, 30 minutes
AND
3) At 45 minutes Tropicamide 0.5% with 2.5% phenylephrine
combination is instilled
If the above strengths are not available( TROPICACYL PLUS, I
TROP –need dilution) then commercially available drops should
be diluted with artificial eye drops and required strength of drops
prepared
 Difficult to dilate eyes could be harboring severe ROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 67
The method for dilatation of the pupils
 Instill one drop only in the conjunctival sac after
pulling the lower lid
 Wipe out the excessive drops that spill out onto the
cheek to prevent systemic absorption through the thin
skin
 Monitor BP and HR, decreased bowel movements,
paralytic ileus and other side effects
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 68
Systemic effects of dilating drops for
retinopathy of prematurity
Increase in BP, heart rate, renal failure,
acute gastric dilatation, paralytic ileus
have all been reported as side effects of
dilating drops24-26
24.Laws et al Br J Ophthalmol. 1996 ;80(5):425-8
25. Shinomiya K et al J Med Invest. 2003;50:203-6
26. Sarici SU et al Pediatr Radiol. 2001 Aug;31(8):581-3
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 69
How to arrange screening
 Start dilating the eyes 1 ½ hour before arrival of
ophthalmologist
 Information leaflet to be given to parents and a
common consent taken for multiple ROP screenings
 ROP examination sheet for each baby should be filled
up and kept ready
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 70
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 71
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 72
Aseptic techniques should be
followed for ROP examination
 Washing hands before and between cases
 Preferably wear sterile gloves for each baby
 Sterile instruments for each baby
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 73
What is done after ROP
examination
 The findings are entered in the ROP sheet in triplicate
by the examining ophthalmologist
 Clear instructions
When is the follow up
Does the child need treatment for ROP or follow up
only?
 The babies in Nursery and OPD who are advised
follow up are to be entered in a separate registers for
follow up --date wise
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 74
Guidelines for follow up intervals
 Follow up intervals depend upon
extent of retinal vascularization
stage of ROP and
presence or absence of pre plus disease
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 75
Follow up intervals-
ophthalmologist decides it
1. More posterior the zone more often do we see the
baby
2. No ROP but retinal vessels in zone I still - every week
3. No ROP but retina vessels in zone II- every 2 weeks
4. Zone I ROP stage 1 or 2 with no plus disease –every
week or earlier
5. Zone II ROP stage 1 no plus disease every 2 weeks
6. Zone II ROP stage 2 or 3 no plus --every one week or
earlier if pre plus present
7. Zone III – No ROP every 2-3 weeks
8. Zone III- ROP stage 1-2 no plus every two weeks
9. Zone III-ROP stage 3 no plus every week
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 76
Appointments on date 26-3-2018
Name of
baby
File
number
DOB Examine
d
BEFORE
S NO of
exam
FU
advice
Remarks
b/o xyz 43^^^^ 24-01-
2018
No 1 After one
week
b/o mnl 34**** 12-02-
2018
Yes 4th exam After 2
weeks
b/o abc 36**** 10-01-2018 Yes 5th exam After one
mo
Discharged
FU given for
OPD
ophthalm
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 77
When should we stop ROP follow
up?
 To be decided by ophthalmologist and not you!
 Babies are to be followed till
a. Retina is fully vascularized both nasally and
temporally
b. If ROP stages were present they completely regress
and retinal vessels reach temporal ora serrata
c. Usually follow ups are needed up to 45-50 weeks of
PCA
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 78
What happens when a baby that needs ROP screening is
discharged home
 See the recommendation of Ophthalmologist in the
last ROP screening
 Give verbal AND written instructions to the parents
regarding date and place of next ROP screening
 The parent’s signature should be taken in a register to
the effect that he/she has been informed about the
need of ROP screening, ITS IMPORTANCE and has
been given a referral letter with date and place of
referral
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 79
What happens when a baby that needs ROP screening is referred
or transferred to another hospital for care
 The referral letter to that center should clearly
mention the scheduled date of ROP screening and
request that hospital to arrange for an ophthalmologist
for it
 Parents should be informed about it and signature
taken
 Documentation regarding these is very important to
avoid legal hassles
 These referrals are to be given by the
NEONATOLOGIST as they are the ones who discharge
or transfer the patient
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 80
FOLLOW UP EXAMINATIONS
after ROP discharge
a. All premature babies with ROP are at high risk of
developing myopia and squint
b. More severe the ROP- greater the degree of myopia
c. ROP treated babies commonly develop high myopia
d. Premature babies even without ROP are at higher
risk of developing myopia AND strabismus
compared to FT babies
e. So these babies need annual examinations even if the
ROP has regressed completely or there was no ROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 81
270 eyes of 148 babies
treated by laser
between 1999 to 2003
20 eyes (7.6%)
Unfavorable
structural outcome
47% of eyes had
VA of <20/40
17% eyes had myopia of 5 D or more
Zone I disease
Was the risk factor
For structural,
refractive and
visual
Unfavorable
Outcomes
82
27. Wani et al Clinical Ophthalmology 2013
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 83
28. Day et al Arch Ophthalmol 2009;127:794-798
Counseling the parents of babies
with Type I ROP-ophthalmologist
 Alert the parents of infants who are nearing Type I
status-pediatrician and ophthalmologist
 An informed consent for treatment for TYPE I
ROP is must
 The ophthalmologist will counsel the parents and
consent taken in the Neonatology
department/OPD
 Even with early treatment of eyes with type I ROP,
some eyes may still progress to an unfavorable
visual and/or structural outcome
 This is especially true for eyes with Zone I disease
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 84
Guidelines for the treatment
 Written informed consent from parents
 Treatment -in operation theater or NICU
 Arrange OT
 Start dilate both eyes 1 ½ hour before timing of laser
 A neonatologist must accompany the child to the OT and
manage emergencies SOS
 IF no contraindication then baby may be given sedation as
appropriate
 Both laser treatment and anti VEGF inj are carried out
under topical anesthesia with infant being restrained by
staff nurse
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 85
POST LASER ROP AFTER 10 YEARS
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 86
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 87
Thanks for your kind attention

More Related Content

Similar to RETINOPATHY OF PREMATURITY FOR PEDIATRICIANS

Lucentis in APROP- byDR AJAY dudani
Lucentis in APROP- byDR AJAY dudaniLucentis in APROP- byDR AJAY dudani
Lucentis in APROP- byDR AJAY dudani
AjayDudani1
 
Fetal megacystis - more than luto - Bàng quang lớn ở thai nhi LUTO
Fetal megacystis - more than luto - Bàng quang lớn ở thai nhi LUTOFetal megacystis - more than luto - Bàng quang lớn ở thai nhi LUTO
Fetal megacystis - more than luto - Bàng quang lớn ở thai nhi LUTO
Võ Tá Sơn
 
Pierre robin syndrome_a_case_report_and_review_of_
Pierre robin syndrome_a_case_report_and_review_of_Pierre robin syndrome_a_case_report_and_review_of_
Pierre robin syndrome_a_case_report_and_review_of_
Ashwini617070
 
retinopathy of prematurity
retinopathy of prematurityretinopathy of prematurity
retinopathy of prematurity
Rohit Rao
 
Fetal acardia in twin gestation
Fetal acardia in twin gestationFetal acardia in twin gestation
Fetal acardia in twin gestation
DR MUKESH SAH
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
Rasika Walpitagamage
 
Retinopathy of prematurity for medical students.pptx
Retinopathy of prematurity for medical students.pptxRetinopathy of prematurity for medical students.pptx
Retinopathy of prematurity for medical students.pptx
doseiha
 
Retinopathy of prematurity.pptx
Retinopathy of prematurity.pptxRetinopathy of prematurity.pptx
Retinopathy of prematurity.pptx
Bipin Koirala
 
Piccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdfPiccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdf
Ramachandra Barik
 
Rop final
Rop finalRop final
Rop final
Ashaq Bhat
 
Presentation for congress for milan ipc 21th march 2013
Presentation for congress for milan ipc 21th march 2013Presentation for congress for milan ipc 21th march 2013
Presentation for congress for milan ipc 21th march 2013
Aso Salih
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
ROHIT KHATRI
 
rop.pptx
rop.pptxrop.pptx
rop.pptx
Harshika Malik
 
Artigo civ e eco fetal
Artigo civ e eco fetalArtigo civ e eco fetal
Artigo civ e eco fetalgisa_legal
 
Lindsay impacto
Lindsay impactoLindsay impacto
Lindsay impactogisa_legal
 
Crouzon Syndrome A Case Report
Crouzon Syndrome A Case ReportCrouzon Syndrome A Case Report
Crouzon Syndrome A Case Report
ijtsrd
 
MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE: A SYNDROME TO RECOGNIZE IN PRE...
MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE: A SYNDROME TO RECOGNIZE IN PRE...MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE: A SYNDROME TO RECOGNIZE IN PRE...
MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE: A SYNDROME TO RECOGNIZE IN PRE...
komalicarol
 
Sub-regional and Global SCD Networks - Jacques Elion
Sub-regional and Global SCD Networks - Jacques ElionSub-regional and Global SCD Networks - Jacques Elion
Sub-regional and Global SCD Networks - Jacques Elion
Human Variome Project
 
Wh fecho criteriafordxrhdnrcardio.2012.7
Wh fecho criteriafordxrhdnrcardio.2012.7Wh fecho criteriafordxrhdnrcardio.2012.7
Wh fecho criteriafordxrhdnrcardio.2012.7
gisa_legal
 
Wh fecho criteriafordxrhdnrcardio.2012.7
Wh fecho criteriafordxrhdnrcardio.2012.7Wh fecho criteriafordxrhdnrcardio.2012.7
Wh fecho criteriafordxrhdnrcardio.2012.7
gisa_legal
 

Similar to RETINOPATHY OF PREMATURITY FOR PEDIATRICIANS (20)

Lucentis in APROP- byDR AJAY dudani
Lucentis in APROP- byDR AJAY dudaniLucentis in APROP- byDR AJAY dudani
Lucentis in APROP- byDR AJAY dudani
 
Fetal megacystis - more than luto - Bàng quang lớn ở thai nhi LUTO
Fetal megacystis - more than luto - Bàng quang lớn ở thai nhi LUTOFetal megacystis - more than luto - Bàng quang lớn ở thai nhi LUTO
Fetal megacystis - more than luto - Bàng quang lớn ở thai nhi LUTO
 
Pierre robin syndrome_a_case_report_and_review_of_
Pierre robin syndrome_a_case_report_and_review_of_Pierre robin syndrome_a_case_report_and_review_of_
Pierre robin syndrome_a_case_report_and_review_of_
 
retinopathy of prematurity
retinopathy of prematurityretinopathy of prematurity
retinopathy of prematurity
 
Fetal acardia in twin gestation
Fetal acardia in twin gestationFetal acardia in twin gestation
Fetal acardia in twin gestation
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
 
Retinopathy of prematurity for medical students.pptx
Retinopathy of prematurity for medical students.pptxRetinopathy of prematurity for medical students.pptx
Retinopathy of prematurity for medical students.pptx
 
Retinopathy of prematurity.pptx
Retinopathy of prematurity.pptxRetinopathy of prematurity.pptx
Retinopathy of prematurity.pptx
 
Piccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdfPiccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdf
 
Rop final
Rop finalRop final
Rop final
 
Presentation for congress for milan ipc 21th march 2013
Presentation for congress for milan ipc 21th march 2013Presentation for congress for milan ipc 21th march 2013
Presentation for congress for milan ipc 21th march 2013
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
 
rop.pptx
rop.pptxrop.pptx
rop.pptx
 
Artigo civ e eco fetal
Artigo civ e eco fetalArtigo civ e eco fetal
Artigo civ e eco fetal
 
Lindsay impacto
Lindsay impactoLindsay impacto
Lindsay impacto
 
Crouzon Syndrome A Case Report
Crouzon Syndrome A Case ReportCrouzon Syndrome A Case Report
Crouzon Syndrome A Case Report
 
MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE: A SYNDROME TO RECOGNIZE IN PRE...
MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE: A SYNDROME TO RECOGNIZE IN PRE...MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE: A SYNDROME TO RECOGNIZE IN PRE...
MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE: A SYNDROME TO RECOGNIZE IN PRE...
 
Sub-regional and Global SCD Networks - Jacques Elion
Sub-regional and Global SCD Networks - Jacques ElionSub-regional and Global SCD Networks - Jacques Elion
Sub-regional and Global SCD Networks - Jacques Elion
 
Wh fecho criteriafordxrhdnrcardio.2012.7
Wh fecho criteriafordxrhdnrcardio.2012.7Wh fecho criteriafordxrhdnrcardio.2012.7
Wh fecho criteriafordxrhdnrcardio.2012.7
 
Wh fecho criteriafordxrhdnrcardio.2012.7
Wh fecho criteriafordxrhdnrcardio.2012.7Wh fecho criteriafordxrhdnrcardio.2012.7
Wh fecho criteriafordxrhdnrcardio.2012.7
 

More from vbwani

DR VIVEK WANI TALK ON DIABETIC RETINOPATHY FOR KLE MBBS STUDENTS UG KAHER.pptx
DR VIVEK WANI TALK ON DIABETIC RETINOPATHY FOR KLE MBBS STUDENTS UG KAHER.pptxDR VIVEK WANI TALK ON DIABETIC RETINOPATHY FOR KLE MBBS STUDENTS UG KAHER.pptx
DR VIVEK WANI TALK ON DIABETIC RETINOPATHY FOR KLE MBBS STUDENTS UG KAHER.pptx
vbwani
 
DR WANI'S TALK ON WHITE DOT SYNDROMES.pptx
DR WANI'S  TALK ON WHITE DOT SYNDROMES.pptxDR WANI'S  TALK ON WHITE DOT SYNDROMES.pptx
DR WANI'S TALK ON WHITE DOT SYNDROMES.pptx
vbwani
 
DR WANI'S TALK ON AMD FOR RESIDENTS 30 March 2020.pptx
DR WANI'S TALK ON AMD FOR RESIDENTS 30 March 2020.pptxDR WANI'S TALK ON AMD FOR RESIDENTS 30 March 2020.pptx
DR WANI'S TALK ON AMD FOR RESIDENTS 30 March 2020.pptx
vbwani
 
DR WANI'S TALK ON RETINAL DETACHMENT LECTURE FOR RESIDENTS [DR WANI TALK.pptx
DR WANI'S  TALK ON RETINAL DETACHMENT LECTURE FOR RESIDENTS [DR WANI TALK.pptxDR WANI'S  TALK ON RETINAL DETACHMENT LECTURE FOR RESIDENTS [DR WANI TALK.pptx
DR WANI'S TALK ON RETINAL DETACHMENT LECTURE FOR RESIDENTS [DR WANI TALK.pptx
vbwani
 
DR WANI'S TALK ON CRVO FOR RESIDENTS KLE 14 JAN 2023.pptx
DR WANI'S TALK ON CRVO FOR RESIDENTS KLE 14 JAN 2023.pptxDR WANI'S TALK ON CRVO FOR RESIDENTS KLE 14 JAN 2023.pptx
DR WANI'S TALK ON CRVO FOR RESIDENTS KLE 14 JAN 2023.pptx
vbwani
 
DR WANI'S TALK ON Diabetic Retinopathy Part II december 31 2022 for KLE RES...
DR WANI'S TALK  ON Diabetic Retinopathy Part II december 31 2022  for KLE RES...DR WANI'S TALK  ON Diabetic Retinopathy Part II december 31 2022  for KLE RES...
DR WANI'S TALK ON Diabetic Retinopathy Part II december 31 2022 for KLE RES...
vbwani
 
DR WANI'S TALK ON DIABETIC RETINOPATHY PART I FOR KLE RESIDENTS.pptx
DR WANI'S TALK ON DIABETIC RETINOPATHY PART I FOR KLE RESIDENTS.pptxDR WANI'S TALK ON DIABETIC RETINOPATHY PART I FOR KLE RESIDENTS.pptx
DR WANI'S TALK ON DIABETIC RETINOPATHY PART I FOR KLE RESIDENTS.pptx
vbwani
 
DR WANI'S TALK ON Fundus fluorescein angiography PART II for post graduates.ppt
DR WANI'S TALK ON Fundus fluorescein angiography PART II for post graduates.pptDR WANI'S TALK ON Fundus fluorescein angiography PART II for post graduates.ppt
DR WANI'S TALK ON Fundus fluorescein angiography PART II for post graduates.ppt
vbwani
 
DR WANI'S TALK ON Fundus fluorescein angiography for post graduates .pptx
DR WANI'S TALK ON Fundus fluorescein angiography for post graduates .pptxDR WANI'S TALK ON Fundus fluorescein angiography for post graduates .pptx
DR WANI'S TALK ON Fundus fluorescein angiography for post graduates .pptx
vbwani
 
DR WANI'S TALK ON Optical coherence tomography of posterior segment FOR KLE ...
DR WANI'S TALK ON Optical coherence tomography of posterior segment  FOR KLE ...DR WANI'S TALK ON Optical coherence tomography of posterior segment  FOR KLE ...
DR WANI'S TALK ON Optical coherence tomography of posterior segment FOR KLE ...
vbwani
 
DR WANI'S TALK ON Retina anatomy for PGs 2022.pptx
DR WANI'S TALK ON Retina anatomy for PGs 2022.pptxDR WANI'S TALK ON Retina anatomy for PGs 2022.pptx
DR WANI'S TALK ON Retina anatomy for PGs 2022.pptx
vbwani
 
DR WANI'STALK ON Anatomy, development and applied anatomy of the vitreous fin...
DR WANI'STALK ON Anatomy, development and applied anatomy of the vitreous fin...DR WANI'STALK ON Anatomy, development and applied anatomy of the vitreous fin...
DR WANI'STALK ON Anatomy, development and applied anatomy of the vitreous fin...
vbwani
 

More from vbwani (12)

DR VIVEK WANI TALK ON DIABETIC RETINOPATHY FOR KLE MBBS STUDENTS UG KAHER.pptx
DR VIVEK WANI TALK ON DIABETIC RETINOPATHY FOR KLE MBBS STUDENTS UG KAHER.pptxDR VIVEK WANI TALK ON DIABETIC RETINOPATHY FOR KLE MBBS STUDENTS UG KAHER.pptx
DR VIVEK WANI TALK ON DIABETIC RETINOPATHY FOR KLE MBBS STUDENTS UG KAHER.pptx
 
DR WANI'S TALK ON WHITE DOT SYNDROMES.pptx
DR WANI'S  TALK ON WHITE DOT SYNDROMES.pptxDR WANI'S  TALK ON WHITE DOT SYNDROMES.pptx
DR WANI'S TALK ON WHITE DOT SYNDROMES.pptx
 
DR WANI'S TALK ON AMD FOR RESIDENTS 30 March 2020.pptx
DR WANI'S TALK ON AMD FOR RESIDENTS 30 March 2020.pptxDR WANI'S TALK ON AMD FOR RESIDENTS 30 March 2020.pptx
DR WANI'S TALK ON AMD FOR RESIDENTS 30 March 2020.pptx
 
DR WANI'S TALK ON RETINAL DETACHMENT LECTURE FOR RESIDENTS [DR WANI TALK.pptx
DR WANI'S  TALK ON RETINAL DETACHMENT LECTURE FOR RESIDENTS [DR WANI TALK.pptxDR WANI'S  TALK ON RETINAL DETACHMENT LECTURE FOR RESIDENTS [DR WANI TALK.pptx
DR WANI'S TALK ON RETINAL DETACHMENT LECTURE FOR RESIDENTS [DR WANI TALK.pptx
 
DR WANI'S TALK ON CRVO FOR RESIDENTS KLE 14 JAN 2023.pptx
DR WANI'S TALK ON CRVO FOR RESIDENTS KLE 14 JAN 2023.pptxDR WANI'S TALK ON CRVO FOR RESIDENTS KLE 14 JAN 2023.pptx
DR WANI'S TALK ON CRVO FOR RESIDENTS KLE 14 JAN 2023.pptx
 
DR WANI'S TALK ON Diabetic Retinopathy Part II december 31 2022 for KLE RES...
DR WANI'S TALK  ON Diabetic Retinopathy Part II december 31 2022  for KLE RES...DR WANI'S TALK  ON Diabetic Retinopathy Part II december 31 2022  for KLE RES...
DR WANI'S TALK ON Diabetic Retinopathy Part II december 31 2022 for KLE RES...
 
DR WANI'S TALK ON DIABETIC RETINOPATHY PART I FOR KLE RESIDENTS.pptx
DR WANI'S TALK ON DIABETIC RETINOPATHY PART I FOR KLE RESIDENTS.pptxDR WANI'S TALK ON DIABETIC RETINOPATHY PART I FOR KLE RESIDENTS.pptx
DR WANI'S TALK ON DIABETIC RETINOPATHY PART I FOR KLE RESIDENTS.pptx
 
DR WANI'S TALK ON Fundus fluorescein angiography PART II for post graduates.ppt
DR WANI'S TALK ON Fundus fluorescein angiography PART II for post graduates.pptDR WANI'S TALK ON Fundus fluorescein angiography PART II for post graduates.ppt
DR WANI'S TALK ON Fundus fluorescein angiography PART II for post graduates.ppt
 
DR WANI'S TALK ON Fundus fluorescein angiography for post graduates .pptx
DR WANI'S TALK ON Fundus fluorescein angiography for post graduates .pptxDR WANI'S TALK ON Fundus fluorescein angiography for post graduates .pptx
DR WANI'S TALK ON Fundus fluorescein angiography for post graduates .pptx
 
DR WANI'S TALK ON Optical coherence tomography of posterior segment FOR KLE ...
DR WANI'S TALK ON Optical coherence tomography of posterior segment  FOR KLE ...DR WANI'S TALK ON Optical coherence tomography of posterior segment  FOR KLE ...
DR WANI'S TALK ON Optical coherence tomography of posterior segment FOR KLE ...
 
DR WANI'S TALK ON Retina anatomy for PGs 2022.pptx
DR WANI'S TALK ON Retina anatomy for PGs 2022.pptxDR WANI'S TALK ON Retina anatomy for PGs 2022.pptx
DR WANI'S TALK ON Retina anatomy for PGs 2022.pptx
 
DR WANI'STALK ON Anatomy, development and applied anatomy of the vitreous fin...
DR WANI'STALK ON Anatomy, development and applied anatomy of the vitreous fin...DR WANI'STALK ON Anatomy, development and applied anatomy of the vitreous fin...
DR WANI'STALK ON Anatomy, development and applied anatomy of the vitreous fin...
 

Recently uploaded

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 

Recently uploaded (20)

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 

RETINOPATHY OF PREMATURITY FOR PEDIATRICIANS

  • 1. DR. VIVEK B WANI MS FRCSED Consultant Vitreoretina surgeon KLES Dr Prabhakar Kore Hospital & RC 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 1
  • 2. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 2 Who is this?
  • 3. OBJECTIVES OF THIS TALK Give an overview of ROP Highlight the role of neonatologists in management of ROP  Which babies are for ROP screening  How to arrange ROP screening  How to manage discharged babies  Medico-legal aspects of ROP 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 3
  • 4. Subheadings of the talk  Overview of ROP  Introduction  Definition of ROP  History and epidemiology  Pathogenesis  ROP clinical features and classification  Risk factors for ROP  Treatment guidelines and results  Role -of neonatologists  Screening protocol  Whom, when, how, follow ups and medico-legal aspects 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 4
  • 5. Introduction WHY SHOULD PEDIATRICIANS KNOW ABOUT ROP?  There are good reasons  There are bad reasons 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 5
  • 6. Good reasons are  By knowing about ROP- you refer at risk babies to ophthalmologists in time and prevent blindness  Blindness in babies is for life  That is a noble service! 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 6
  • 7. Prompt reference, proper screening and laser treatment done in BE 20 years ago -Now a graduate in US 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 7
  • 8. Bad reasons to know about ROP 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 8 BE AWARE OF ALL PROTOCOLS AND DO YOUR PART IN CARE OF ROP TO AVOID SUCH MEDICOLEGAL cases
  • 9. Definition of ROP? ROP is a vaso- proliferative disorder of the retina in premature babies with immature retina - avascular area 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 9
  • 10. History of ROP 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 10 Terry 1942 -- two cases of white membranes behind the lenses in premature babies and termed it as Retrolental Fibroplasia (RLF)1 Campbell and Patz showed that premature babies receiving higher oxygen supplementation developed RLF2,3 , 1.Terry TL. Am J Ophthalmol 1942;25:203-204 2. Campbell K. Med J Aust 1951;2:48–50 3. Patz et al Am J Ophthalmol 1952;35:1248–52
  • 11. Knee jerk reaction-curtail oxygen  Reducing oxygen led to reduction in RLF from 50% to 4%4  BUT- a very high rate of mortality and morbidity due to cerebral palsy 5  It was estimated that by reducing oxygen-for every baby they saved the sight- there were 16 babies who either died or had cerebral palsy6  So oxygen was restarted to be used 4. Hatfield EM. Sight Sav Rev 1972;42:69–89 5.. Avery ME, Oppenheimer EH. J Pediatr 1960;57:553–9. 6. Cross KW. Cost of preventing retrolental fibroplasia? Lancet. 1973;2:954–6 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 11
  • 12. Three Epidemics of ROP  First epidemic of RLF or ROP was in 1940s- 50s –soon after oxygen was introduced for premature babies- none knew about ROP  Second epidemic started in 70s-80s Due to liberal use of oxygen to prevent cerebral palsy or death7 Due to increased survival of smaller babies8 7.Gibson DL et al Pediatrics 1989;83:486–92. 8.Valentine PH et al. Pediatrics 1989;84:442–5 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 12
  • 13. The third epidemic -1990s onwards  Advances and expansion of neonatal services in middle income countries like India, China, Mexico, Brazil etc are occurring  More premature babies are surviving  So ROP is increasing in these countries -3RD WAVE  It is still going on  It is our duty to expand ROP services to cover every neonate 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 13
  • 14. How big is ROP problem?  13 million premature babies born every year in the world  And severe ROP in more than 50 000 babies every year9  One in 820 babies born premature may become blind due to ROP10  An estimated 32000 children went blind world wide in 2010 and 10% of them were in India11  ROP is an important cause of blindness during childhood12 9. Blencowe H et al. Pediatr Res. 2013;74(Suppl 1):35-49 10. Lad et al Br J Ophthalmol 2008;92:320-325 11. Blencowe H et al Indiann Paediattrics 2016;53:supl 2 12. Steinkuller PG et al J AAPOS 1999;3:26 –32. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 14
  • 15. How does fetal retinal vasculature develop? 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 15 • At 12 weeks of gestation mesenchymal cells grow out from the disc • They form capillaries, venules and arterioles and then major vessels • The avascular retina produce a cytokine vascular endothelial growth factor – VEGF-which promotes vascularization of retina • Vessels reach nasal periphery- ora serrata- at 32 weeks of gestation and temporal periphery at term • So by term, the retina is fully vascularized LEFT EYE
  • 16. So if a baby is born premature  Some avascular retina will be present -extent depends upon prematurity  In such babies retinal vessels may grow towards the ora to complete vascularization of retina in a normal fashion or ROP may develop in some 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 16
  • 17. Pathogenesis Pathogenesis of ROP occurs in two phases13-15  Hyperoxic phase  Hypoxic phase 13. Chen J, Smith LE. Angiogenesis. 2007;10:133-140. 14. Hartnett ME. Ophthalmology. 2015;122:200-210. 15. Mintz-Hitner HA et al N Engl J Med. 2011;364:603-615 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 17
  • 18. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 18 In utero baby lives in hypoxic environment -PaO2 of < 30 mm of Hg. Hypoxia promotes normal VEGF expression which facilitates vascularization of retina If a baby is born premature it is exposed to higher PaO2 of 100 mm of Hg in room air. Baby may also receive O2 treatment High PaO2 –no hypoxia - VEGF expression suppressed –needed for normal growth of blood vessels -so vessel growth stops –vaso-cessation high PaO2 in blood -O2 radicals –death of endothelial cells of growing retinal vessels –cause obliteration –vaso-obliteration Vessels and capillaries stop growing to periphery The peripheral retina remains avascular - becomes hypoxic - hypoxia triggers next phase of pathogenesis-HYPOXIC PHASE HYPEROXIC PHASE 22 to 30 weeks of PMA
  • 19. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 19 Phase 2 –HYPOXIC PHASE-31 to 44 weeks of PCA Hypoxia causes up-regulation of VEGF and other growth factors in retinal cells in avascular retina High VEGF and other growth factors lead to active ROP and abnormal vaso-proliferation ROP develops at the junction between vascularized and avascular retina These cells now produce VEGF, EPO and IGF1 VEGF levels increase -130 times normal values
  • 20. . 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 20 16. Invest. Ophthalmol. Vis. Sci.. 2008;49(12):5177-5182
  • 21. Classification of ROP  International classification of ROP(ICROP) 17 issued guidelines to uniformly describe ROP in 1984  Further modifications for this have occurred subsequently but basic aspects remain same 17. ICROP GROUP Arch Ophthalmol 1984;102:1130-1134 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 21
  • 22. ROP – ICROP17 1) Location 2) Staging 3) Extent 4) Plus disease 17. ICROP GROUP Arch Ophthalmol 1984;102:1130-1134 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 22
  • 23. 1) Location –Zone- tells us where the disease is located 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 23
  • 24. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 24
  • 25. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 25
  • 26. 2) Stages of ROP Stage 1-demarcation line A simple flat line is seen at the edge of advancing vessels separating avascular from vascular retina Stage 2-Ridge The demarcation line becomes thick and has volume and height –then it is called as ridge-stage 2 It is pinkish or whitish 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 26
  • 27. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 27
  • 28. Stage 3  When new blood vessels called as extra-retinal proliferations (ERP) develop in addition to the ridge New vessels may grow into vitreous or back on the surface of vascularized retina from the ridge area giving it ragged appearance 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 28
  • 29. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 29
  • 30. Stage 3 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 30
  • 31. Do all babies who develop stage 1 or 2 progress to stage 3 ROP? No  Many babies who develop stage 1 or 2 show spontaneous resolution of disease  Retina may become fully vascularized  Some cases of Stage 3 also show regression 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 31
  • 32. We should not see this stage Stage 4-subtotal retinal detachment When extensive ERP contract they pull retina TRD Stage 4a  Macula not involved Stage 4b  Macula is involved 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 32
  • 33. Stage 5- we should never see it  Total retinal detachment  Results of surgery very poor 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 33
  • 34. 3) ICROP- Extent of the disease  We note how many clock hours of disease is present  Report as so many clock hours of the disease 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 34
  • 35. 4) ICROP- 4th component is plus disease MOST IMPORTANT SIGN  Dilatation and tortuosity of the posterior vessels in zone 1  Vitreous haze  Pupil rigidity-does not dilate well  Iris vessel engorgement, iris new vessels PLUS disease is a very important sign and its presence is usually an indication for treatment Further classified as pre-plus or plus 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 35
  • 36. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 36
  • 37. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 37
  • 38. Tunica vasculosa lentis 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 38
  • 39. ZONE I stage 3 plus disease 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 39
  • 40. When do we treat ROP  The purpose of screening is to catch ROP at treatable stage and prevent stages 4 and 5  The window of opportunity is small in ROP  One missed appointment -baby may progress from stage 2 to stage 4 or stage 5  So screening a timely protocol is very important  RCTs have established guidelines for treatment  We follow ETROP study guidelines for indications of treatment 18 18. Early Treatment of Retinopathy of Prematurity Group. Arch Ophthalmol. 2003;121:1684-1694 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 40
  • 41. Type1 ROP (treatment is required)18  Zone I-stage 1 OR 2 ROP with plus disease  Zone I-stage 3 ROPeven without plus disease  Zone II-stage 2 or 3 withplus disease Treatment is  Retinal ablation of all the avascular retina by laser is established form of treatment  However presently zone I ROP is treated by intravitreal injection of anti VEGF 18.Early Treatment of Retinopathy of Prematurity Group. Arch Ophthalmol. 2003;121:1684-1694 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 41
  • 42. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 42
  • 43. ROP that does not meet the criteria of type 1 ROP is termed as Type 2 ROP  Zone I, stage 1 or 2 ROP without plus disease  Zone II, stage 2 or stage3 ROP without plus disease  No treatment is required at that point of time  But continued follow up is needed  If progresses to type I treat the baby 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 43
  • 44. Aggressive ROP-AROP or APROP  It is fulminant variant of ROP  Seen usually in very small babies  ROP is in the zone 1 or posterior zone 2  Rapidly progresses to higher stages without starting with stage 1 or 2  Has disproportionate plus disease  Neovascularization of retina may be intraretinal  Treatment results are less satisfactory 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 44
  • 45. ZONE I DISEASE - APROP 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 45
  • 46. How do we treat A) Laser –laser burns applied to all the avascular retina which is hypoxic -is producing VEGF. Once is ‘destroyed’ VEGF comes down and The ROP regresses B) Anti VEGF injections–in eyes with zone I disease or aggressive ROP(A-ROP)  Anti VEGF – it neutralizes high levels of VEGF in the eye and stops neovascularization 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 46
  • 47. Laser treatment 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 47
  • 48. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 48
  • 49. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 49
  • 50. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 50
  • 51. What are the risk factors for ROP  Lower Gestational age at birth-prematurity  Lower Birth weight-prematurity  Oxygen administration  Need for ventilation  HMD  CLD  Sepsis  Intra-ventricular hemorrhage  Need for blood transfusion  Poor postnatal weight gain  NEEC  PDA  Many other factors 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 51
  • 52. Oxygen spO2  Keeping SpO2 83% and 93% from birth and during transport virtually eliminated severe ROP  Need for laser treatment was 4.5% for high SpO2 (90%–98%) versus 0% for low SpO2 (85%–93%)19 19.Chow LC, et al . Pediatrics. 2003;111:339–45. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 52
  • 53. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 53 EVENT HIGHER OXYGEN 91-95% LOWER OXYGEN 85-89% RR LEVEL P VALUE MEANI NG PRIMARY OUTCOME 51.6% 53.5% P=0.21 NS DEATH 17.1% 19.9% P=0.01 S ROP treatment need 14.9% 10.9% P < .001 S NEEC 6.9% 9.2% P = .003 S NEOPROM STUDY20 20. Askie LM et al JAMA. 2018 Jun 5;319(21):2190-2201.
  • 54. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 54 21 21. Wani et al Indian J Ophhthlamol 2010;58: 204-208
  • 55. 22. Middle East Afr J Ophthalmol.2013;20(1):66-71. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 55
  • 56. Incidence of ROP and type I ROP-KLE experience 2019 one year data 1/6/2023 56 Study and place of study Number of infants Inclusion criteria GA* and BW† Mean BW± SD in grams GA± SD in weeks Any ROP% Type 1 ROP% Quinn et al 6 USA 7483 GA≤30 BW<1500g 28 ± 3 1099± 259 43.1 6.9 Braimah et al7 Ghana 401 GA<37 BW<2000 32.2± 2.4 1600± 400 13.7 1.8 Bas et al 10 Turkey 6115 GA<32 W BW <1500G 1457±479 28.9±6.3 27 6.7 Ahuja et al11 India 325 GA≤36 W BW ≤1900G 1420±300 30.68±2.84 32.6 13.2 Vinekar et al 14 India 4167 GA<34 BW<2000G 1592.7 31.7 24.33 4.4 Castellon et al21 Mexico 132 GA≤34 BW <1700g 1594±96 32±3 56.1 28.8 ETROP study23 USA 6998 BW <1251g 907 27.4 68 36.9 Present study 263 GA<34 BW<2000G 1598.8 ±440.1 33± 2.8 24.3 5.7
  • 57. Results of treatment of ROP till 2021 in KLE  55 babies(KLE BORN AND OUTSIDE BORN)  GA 30.1( 27-33)weeks  BWT 1299.7( 718-2500)g  PCA at treatment 35.9 weeks  AROP in 6 babies  20 treated by anti vegf injections  None developed RD 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 57
  • 58. Role of Pediatricians in ROP Which premature babies to screen?23 Following guidelines are from Govt. of India  Birth weight(BW) less than or = 2000g  Gestational age(GA) less than or =34 weeks  GA 34-36 weeks n BW >2000G but has following risk factors a) Cardiopulmonary support b) Prolonged oxygen administration c)Respiratory distress syndrome d) Chronic lung disease e)Fetal hemorrhage f)Blood transfusion g)Neonatal infection h)Exchange transfusion i)Intraventricular hemorrhage j)Apneas k)Poor postnatal weight gain  Infants with unstable clinical course who are at high risk (as determined by neonatologist) 23 https://nhm.gov.in/images/pdf/programmes/RBSK/Resource_Documents/Revised_ROP_Guidelines-Web_Optimized.pdf 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 58
  • 59. Who chooses the babies for screening?  The neonatologist will choose the babies  All the names of eligible babies are entered in a register by an assigned staff and date for first screening to be entered in the register 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 59
  • 60. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 60 Rashtriya Bala Swasthya Karykrama June 201723
  • 61. When to perform the first ROP screening?23  Early screening for babies born with GA < 28 weeks OR babies with BW<1200g -first ROP screening at 2-3 weeks after birth (To detect AROP)  All other babies undergo the first ROP screening at four weeks after birth 23. https://nhm.gov.in/images/pdf/programmes/RBSK/Resource_Documents/Revised_ROP_Guidelines- Web_Optimized.pdf 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 61
  • 62. Sample register entry Name of baby IP nu mbe r DOB SE X GA wk s BW g I ROP screening date Mobile of parent s b/o ABC I twin 32** **** 01/01/2018 M 29 1150 14 or 21 of January 2018 988**** *** b/o ABC II twin 32** **** 01/01/2018 M 29 1240 28TH JAN 2018 same b/o MNO 33** **** 25/01/2018 F 30 1400 25/2/2018 944**** *** 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 62
  • 63. Baby unfit for eye examination In case the baby is too sick to tolerate dilatation & ROP screening is postponed Neonatologist should  Clearly write in the case sheet the reason for cancellation of screening examination  ROP screening at the earliest possible to be arranged  Inform the parents 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 63
  • 64. Who performs the screening?  It is an ophthalmologist who is experienced in ROP examination and management 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 64
  • 65. Arrangement regarding visit of the Ophthalmologist to the nursery  Neonatology and Ophthalmologist should arrange day/days to conduct ROP screening examination/s  Usually a fixed day and timings are preferred to avoid confusion except under special circumstances 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 65
  • 66. Arrangement regarding visit of the Ophthalmologist to the nursery  The staff of NICU should inform the timing of eye examination to all the sections of the Neonatology dept-NICU, WARDS, OPDs  Babies for first time ROP screening and follow up examinations are to be included (see later)  Keep the pupils dilated of all the selected babies 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 66
  • 67. The method for dilatation of the pupils 1) 0.5% Tropicamide every 15 minutes for three times-0,15,30 minutes OR 2) Cyclopentolate 0.5% eye drops (Cyclogyl) to be used every 15 minutes for three times 0, 15, 30 minutes AND 3) At 45 minutes Tropicamide 0.5% with 2.5% phenylephrine combination is instilled If the above strengths are not available( TROPICACYL PLUS, I TROP –need dilution) then commercially available drops should be diluted with artificial eye drops and required strength of drops prepared  Difficult to dilate eyes could be harboring severe ROP 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 67
  • 68. The method for dilatation of the pupils  Instill one drop only in the conjunctival sac after pulling the lower lid  Wipe out the excessive drops that spill out onto the cheek to prevent systemic absorption through the thin skin  Monitor BP and HR, decreased bowel movements, paralytic ileus and other side effects 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 68
  • 69. Systemic effects of dilating drops for retinopathy of prematurity Increase in BP, heart rate, renal failure, acute gastric dilatation, paralytic ileus have all been reported as side effects of dilating drops24-26 24.Laws et al Br J Ophthalmol. 1996 ;80(5):425-8 25. Shinomiya K et al J Med Invest. 2003;50:203-6 26. Sarici SU et al Pediatr Radiol. 2001 Aug;31(8):581-3 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 69
  • 70. How to arrange screening  Start dilating the eyes 1 ½ hour before arrival of ophthalmologist  Information leaflet to be given to parents and a common consent taken for multiple ROP screenings  ROP examination sheet for each baby should be filled up and kept ready 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 70
  • 71. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 71
  • 72. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 72
  • 73. Aseptic techniques should be followed for ROP examination  Washing hands before and between cases  Preferably wear sterile gloves for each baby  Sterile instruments for each baby 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 73
  • 74. What is done after ROP examination  The findings are entered in the ROP sheet in triplicate by the examining ophthalmologist  Clear instructions When is the follow up Does the child need treatment for ROP or follow up only?  The babies in Nursery and OPD who are advised follow up are to be entered in a separate registers for follow up --date wise 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 74
  • 75. Guidelines for follow up intervals  Follow up intervals depend upon extent of retinal vascularization stage of ROP and presence or absence of pre plus disease 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 75
  • 76. Follow up intervals- ophthalmologist decides it 1. More posterior the zone more often do we see the baby 2. No ROP but retinal vessels in zone I still - every week 3. No ROP but retina vessels in zone II- every 2 weeks 4. Zone I ROP stage 1 or 2 with no plus disease –every week or earlier 5. Zone II ROP stage 1 no plus disease every 2 weeks 6. Zone II ROP stage 2 or 3 no plus --every one week or earlier if pre plus present 7. Zone III – No ROP every 2-3 weeks 8. Zone III- ROP stage 1-2 no plus every two weeks 9. Zone III-ROP stage 3 no plus every week 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 76
  • 77. Appointments on date 26-3-2018 Name of baby File number DOB Examine d BEFORE S NO of exam FU advice Remarks b/o xyz 43^^^^ 24-01- 2018 No 1 After one week b/o mnl 34**** 12-02- 2018 Yes 4th exam After 2 weeks b/o abc 36**** 10-01-2018 Yes 5th exam After one mo Discharged FU given for OPD ophthalm 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 77
  • 78. When should we stop ROP follow up?  To be decided by ophthalmologist and not you!  Babies are to be followed till a. Retina is fully vascularized both nasally and temporally b. If ROP stages were present they completely regress and retinal vessels reach temporal ora serrata c. Usually follow ups are needed up to 45-50 weeks of PCA 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 78
  • 79. What happens when a baby that needs ROP screening is discharged home  See the recommendation of Ophthalmologist in the last ROP screening  Give verbal AND written instructions to the parents regarding date and place of next ROP screening  The parent’s signature should be taken in a register to the effect that he/she has been informed about the need of ROP screening, ITS IMPORTANCE and has been given a referral letter with date and place of referral 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 79
  • 80. What happens when a baby that needs ROP screening is referred or transferred to another hospital for care  The referral letter to that center should clearly mention the scheduled date of ROP screening and request that hospital to arrange for an ophthalmologist for it  Parents should be informed about it and signature taken  Documentation regarding these is very important to avoid legal hassles  These referrals are to be given by the NEONATOLOGIST as they are the ones who discharge or transfer the patient 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 80
  • 81. FOLLOW UP EXAMINATIONS after ROP discharge a. All premature babies with ROP are at high risk of developing myopia and squint b. More severe the ROP- greater the degree of myopia c. ROP treated babies commonly develop high myopia d. Premature babies even without ROP are at higher risk of developing myopia AND strabismus compared to FT babies e. So these babies need annual examinations even if the ROP has regressed completely or there was no ROP 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 81
  • 82. 270 eyes of 148 babies treated by laser between 1999 to 2003 20 eyes (7.6%) Unfavorable structural outcome 47% of eyes had VA of <20/40 17% eyes had myopia of 5 D or more Zone I disease Was the risk factor For structural, refractive and visual Unfavorable Outcomes 82 27. Wani et al Clinical Ophthalmology 2013 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI
  • 83. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 83 28. Day et al Arch Ophthalmol 2009;127:794-798
  • 84. Counseling the parents of babies with Type I ROP-ophthalmologist  Alert the parents of infants who are nearing Type I status-pediatrician and ophthalmologist  An informed consent for treatment for TYPE I ROP is must  The ophthalmologist will counsel the parents and consent taken in the Neonatology department/OPD  Even with early treatment of eyes with type I ROP, some eyes may still progress to an unfavorable visual and/or structural outcome  This is especially true for eyes with Zone I disease 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 84
  • 85. Guidelines for the treatment  Written informed consent from parents  Treatment -in operation theater or NICU  Arrange OT  Start dilate both eyes 1 ½ hour before timing of laser  A neonatologist must accompany the child to the OT and manage emergencies SOS  IF no contraindication then baby may be given sedation as appropriate  Both laser treatment and anti VEGF inj are carried out under topical anesthesia with infant being restrained by staff nurse 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 85
  • 86. POST LASER ROP AFTER 10 YEARS 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 86
  • 87. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 87 Thanks for your kind attention